Thus, researchers have actively explored the development of novel therapeutic options derived from natural herbs or their active components that have the potential to suppress AD-like skin inflammation by modulating JAK/STAT signaling [8,16], providing promising alternatives therapeutics with potentially fewer adverse effects. The gene discussed is SOAT1; the disease is dermatitis.